1. Home
  2. TALK vs STOK Comparison

TALK vs STOK Comparison

Compare TALK & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TALK
  • STOK
  • Stock Information
  • Founded
  • TALK 2012
  • STOK 2014
  • Country
  • TALK United States
  • STOK United States
  • Employees
  • TALK N/A
  • STOK N/A
  • Industry
  • TALK Medical/Nursing Services
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • TALK Health Care
  • STOK Health Care
  • Exchange
  • TALK Nasdaq
  • STOK Nasdaq
  • Market Cap
  • TALK 434.6M
  • STOK 517.0M
  • IPO Year
  • TALK N/A
  • STOK 2019
  • Fundamental
  • Price
  • TALK $3.02
  • STOK $9.36
  • Analyst Decision
  • TALK Buy
  • STOK Strong Buy
  • Analyst Count
  • TALK 6
  • STOK 5
  • Target Price
  • TALK $4.50
  • STOK $27.50
  • AVG Volume (30 Days)
  • TALK 1.5M
  • STOK 776.7K
  • Earning Date
  • TALK 05-06-2025
  • STOK 05-20-2025
  • Dividend Yield
  • TALK N/A
  • STOK N/A
  • EPS Growth
  • TALK N/A
  • STOK N/A
  • EPS
  • TALK 0.02
  • STOK N/A
  • Revenue
  • TALK $194,359,000.00
  • STOK $36,555,000.00
  • Revenue This Year
  • TALK $23.21
  • STOK $27.80
  • Revenue Next Year
  • TALK $20.87
  • STOK $9.53
  • P/E Ratio
  • TALK $173.65
  • STOK N/A
  • Revenue Growth
  • TALK 19.88
  • STOK 316.34
  • 52 Week Low
  • TALK $1.60
  • STOK $5.35
  • 52 Week High
  • TALK $4.36
  • STOK $17.58
  • Technical
  • Relative Strength Index (RSI)
  • TALK 52.96
  • STOK 57.94
  • Support Level
  • TALK $2.75
  • STOK $8.30
  • Resistance Level
  • TALK $3.30
  • STOK $10.12
  • Average True Range (ATR)
  • TALK 0.19
  • STOK 0.59
  • MACD
  • TALK 0.00
  • STOK -0.03
  • Stochastic Oscillator
  • TALK 58.82
  • STOK 58.24

About TALK Talkspace Inc.

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: